Study Unveils Genetic Link Between TNF Deficiency and Recurrent Tuberculosis

August 28, 2024
Study Unveils Genetic Link Between TNF Deficiency and Recurrent Tuberculosis
  • Whole-exome sequencing identified a frameshift variant in the TNF gene common to both patients, suggesting a genetic cause for their TB.

  • These findings raise questions about the traditional understanding of TNF's importance in immunity, particularly its link to tuberculosis susceptibility.

  • The research clarifies why TNF inhibitors, commonly used to treat autoimmune diseases, increase the risk of TB by compromising the immune defense against it.

  • Ultimately, the study suggests a reevaluation of TNF's role in immunity, which could lead to new treatment strategies focusing on other cytokines responsible for immune responses.

  • With around 25% of the global population infected with Mtb, genetic factors significantly influence the likelihood of developing TB, as only 5-10% of those infected will actually become ill.

  • A recent study published in Nature reveals that the immune-signaling protein TNF is critical for inflammatory responses in humans and plays a narrower role in immunity than previously thought.

  • Led by researchers Stépahnie Boisson-Dupuis and Jean-Laurent Casanova, the study emphasizes the genetic basis of recurrent TB linked to TNF deficiency, highlighting how genetic mutations affect immune responses and disease susceptibility.

  • Genetic analysis revealed that both patients had a mutation in the TNF gene, which is crucial for regulating immune responses and inflammation.

  • The absence of functional TNF led to an inability to produce reactive oxygen species (ROS), allowing Mycobacterium tuberculosis (Mtb) to proliferate unchecked in the patients' lungs.

  • This impaired ROS production in macrophages is critical for controlling Mtb, underscoring the importance of TNF signaling in macrophage function.

  • Tuberculosis (TB) remains the leading cause of death from infectious diseases worldwide, with only about 5% of infections resulting in death.

  • The research focused on two patients from a consanguineous Colombian family who experienced severe, recurring TB infections despite having otherwise normal immune systems.

Summary based on 3 sources


Get a daily email with more Science stories

More Stories